Home
Search

Search

337 - 348 of 386 result(s)
Sort by
Date published
Date published
337 - 348 of 386 result(s)

  1. Regulatory Impact Assessment: Interim Supplementary Analysis Report: Arms (Prohibited Firearms, Magazines, and Parts) Amendment Bill (No. 1) 2019

    Issue Date: 02 April 2019 Author: New Zealand Police

  2. Regulatory Impact Assessment: Impact Summary: Proposals to improve the risk management of semi-automatic pistols

    Issue Date: 21 November 2019 Author: New Zealand Police

  3. Regulatory Impact Assessment: Regulatory Impact Analysis: Arms Legislation Bill

    Issue Date: 13 September 2019 Author: New Zealand Police

  4. Regulatory Impact Assessment: Implementation of Arms Amnesty: Compensation for individuals and dealers and prohibition of certain types of ammunition

    Issue Date: 05 August 2019 Author: New Zealand Police

  5. Regulatory Impact Statement: Child Protection Offender Register and Risk Management Framework

    Issue Date: 14 August 2015 Author: New Zealand Police

  6. Regulatory Impact Statement: Arms

    Issue Date: 15 April 2011 Author: New Zealand Police

  7. Ministry’s next regulatory review – telecommunications sector

    The Ministry for Regulation’s fourth regulatory review will be into the telecommunications sector.

  8. Formal training opportunities

    If you're interested in further study options, there are more formal regulatory practice courses available. These are provided through various training organisations, and both online and in-person options are available.

  9. Regulatory Impact Statement (RIS) template

    20 December 2024 The standard RIS template for government regulatory proposals.

  10. Regulatory stewardship

    We provide system leadership, set standards for good regulatory practice, and support agencies with their regulatory stewardship responsibilities.

  11. Copyright and disclaimer

    This copyright and disclaimer information relates to the use of material published on this website.

  12. No more missing out on medical conferences

    We’ve completed a rapid review of the rules around ads for yet to be approved medicines at medical trade shows.